About NAD
What is NAD⁺ NAD⁺ Precursors Scientific Analysis Press
Clinical Studies Preclinical Studies
What is NAD⁺NAD⁺ Precursors Studies Clinical Studies Preclinical Studies Scientific AnalysisPress
About NAD
Our mission is to provide a balanced look at NAD’s role in human health by providing the latest educational and scientifically proven content to the public.

Boosting anti-cancer action by driving up immunity at tumor site

Reposted from EurekAlert!

 

New research suggests that driving up the immune response at the site of a cancer tumor with nanotechnology may help enhance immunotherapy treatments in advanced stages of the disease.

See Original Post
In The NewsANAD StaffDecember 14, 2021
Facebook0 Twitter Pinterest0 0 Likes
Previous

Viral Infection as an NAD+ Battlefield

In The NewsANAD StaffJanuary 3, 2022
Next

Depression: Has brain network modulation come of age?

In The NewsANAD StaffDecember 13, 2021

Advance Your NAD+ knowledge

Subscribe for the latest in NAD+ and nicotinamide riboside (NR) clinical and preclinical research news. Delivered straight to your inbox.

Thank you!

ARTICLE CATEGORIES

  • Scientific Analysis

  • Studies

  • Press

WHAT IS NAD⁺

  • A Timeline to NAD Research

  • A Brief Introduction to NAD

  • NAD Levels Are Not Constant

  • Improving NAD Status to Support Cellular Resilience

  • NAD Biosynthesis & Metabolome

  • Glossary

About

  • About Us

  • Frequently Asked Questions

Stay Connected

Scientific Analysis RSS
Clinical Studies RSS
Press RSS
RSS Block
Select a Blog Page to create an RSS feed link. Learn more
RSS

© Copyright 2020 AboutNAD

Terms of Use,  Privacy Policy,  California Consumer Privacy Statement,  Consumer Health Data Privacy Statement and  Accessibility Statement   Accessibility Statement Logo

AboutNAD is curated by Niagen Bioscience, Inc. and the content of this site is intended for educational purposes only.